766508-67-2 Usage
General Description
4-(3'-Carboxyphenyl)piperidine, also known as 3-carboxy-4-phenylpiperidine, is a chemical compound that belongs to the class of piperidine derivatives. It consists of a piperidine ring with a phenyl group and a carboxylic acid functional group attached to it. 4-(3'-Carboxyphenyl)piperidine has potential pharmaceutical applications due to its structural resemblance to other biologically active molecules. It may be utilized in the development of new drugs for conditions such as neurological disorders, pain management, and psychiatric illnesses. Additionally, it has also been studied for its potential role as a ligand for various receptors and enzymes, which could further contribute to its pharmacological significance.
Check Digit Verification of cas no
The CAS Registry Mumber 766508-67-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,6,5,0 and 8 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 766508-67:
(8*7)+(7*6)+(6*6)+(5*5)+(4*0)+(3*8)+(2*6)+(1*7)=202
202 % 10 = 2
So 766508-67-2 is a valid CAS Registry Number.
InChI:InChI=1/C12H15NO2/c14-12(15)11-3-1-2-10(8-11)9-4-6-13-7-5-9/h1-3,8-9,13H,4-7H2,(H,14,15)
766508-67-2Relevant articles and documents
Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities
Tang, Haifeng,Yan, Yan,Feng, Zhe,De Jesus, Reynalda K.,Yang, Lihu,Levorse, Dorothy A.,Owens, Karen A.,Akiyama, Taro E.,Bergeron, Raynald,Castriota, Gino A.,Doebber, Thomas W.,Ellsworth, Kenneth P.,Lassman, Michael E.,Li, Cai,Wu, Margaret S.,Zhang, Bei B.,Chapman, Kevin T.,Mills, Sander G.,Berger, Joel P.,Pasternak, Alexander
scheme or table, p. 6088 - 6092 (2010/11/18)
A new series of thiazole-substituted 1,1,1,3,3,3-hexafluoro-2-propanols were prepared and evaluated as malonyl-CoA decarboxylase (MCD) inhibitors. Key analogs caused dose-dependent decreases in food intake and body weight in obese mice. Acute treatment with these compounds also led to a drop in elevated blood glucose in a murine model of type II diabetes.
